Literature DB >> 24225752

p63 expression in Merkel cell carcinoma predicts poorer survival yet may have limited clinical utility.

Galina Y Stetsenko1, Jacqueline Malekirad, Kelly G Paulson, Jayasri G Iyer, Renee M Thibodeau, Kotaro Nagase, Miranda Schmidt, Barry E Storer, Zsolt B Argenyi, Paul Nghiem.   

Abstract

OBJECTIVES: To determine the clinical utility of p63 expression, which has been identified in several cohorts as a predictor of poorer prognosis in Merkel cell carcinoma (MCC).
METHODS: Immunohistochemistry was used to determine p63 expression on MCC tumors from 128 patients.
RESULTS: Of the patients, 33% had detectable p63 expression. p63 Positivity was associated with an increased risk of death from MCC (hazard ratio, 2.05; P = .02) in a multivariate Cox regression model considering stage at presentation, age at diagnosis, and sex. Although p63 expression correlated with diminished survival in this largest cohort reported thus far, the effect was weaker than that observed in prior studies. Indeed, within a given stage, p63 status did not predict survival in a clinically or statistically significant manner.
CONCLUSIONS: It remains unclear whether this test should be integrated into routine MCC patient management.

Entities:  

Keywords:  Merkel cell carcinoma; Prognosis; Survival; p63

Mesh:

Substances:

Year:  2013        PMID: 24225752      PMCID: PMC4074520          DOI: 10.1309/AJCPE4PK6CTBNQJY

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  20 in total

1.  Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system.

Authors:  Bianca D Lemos; Barry E Storer; Jayasri G Iyer; Jerri Linn Phillips; Christopher K Bichakjian; L Christine Fang; Timothy M Johnson; Nanette J Liegeois-Kwon; Clark C Otley; Kelly G Paulson; Merrick I Ross; Siegrid S Yu; Nathalie C Zeitouni; David R Byrd; Vernon K Sondak; Jeffrey E Gershenwald; Arthur J Sober; Paul Nghiem
Journal:  J Am Acad Dermatol       Date:  2010-06-19       Impact factor: 11.527

2.  The use of immunohistochemistry for diagnosis of prostate cancer.

Authors:  Katia R M Leite; Miguel Srougi; Adriana Sanudo; Marcos F Dall'oglio; Adriano Nesrallah; Alberto A Antunes; Jose Cury; Luiz H Camara-Lopes
Journal:  Int Braz J Urol       Date:  2010 Sep-Oct       Impact factor: 1.541

3.  Expression of p63 is the sole independent marker of aggressiveness in localised (stage I-II) Merkel cell carcinomas.

Authors:  Sofia Asioli; Alberto Righi; Dario de Biase; Luca Morandi; Virginia Caliendo; Franco Picciotto; Giuseppe Macripò; Francesca Maletta; Ludovica Verdun di Cantogno; Luigi Chiusa; Vincenzo Eusebi; Gianni Bussolati
Journal:  Mod Pathol       Date:  2011-07-15       Impact factor: 7.842

4.  Increasing tumor thickness is associated with recurrence and poorer survival in patients with Merkel cell carcinoma.

Authors:  Cathy S Lim; Deborah Whalley; Lauren E Haydu; Rajmohan Murali; Jill Tippett; John F Thompson; George Hruby; Richard A Scolyer
Journal:  Ann Surg Oncol       Date:  2012-07-21       Impact factor: 5.344

5.  p63 expression profiles in human normal and tumor tissues.

Authors:  Charles J Di Como; Marshall J Urist; Irina Babayan; Marija Drobnjak; Cyrus V Hedvat; Julie Teruya-Feldstein; Kamal Pohar; Axel Hoos; Carlos Cordon-Cardo
Journal:  Clin Cancer Res       Date:  2002-02       Impact factor: 12.531

6.  Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies.

Authors:  K S McCarty; L S Miller; E B Cox; J Konrath; K S McCarty
Journal:  Arch Pathol Lab Med       Date:  1985-08       Impact factor: 5.534

7.  p63 overexpression associates with poor prognosis in head and neck squamous cell carcinoma.

Authors:  Lorenzo Lo Muzio; Andrea Santarelli; Rosario Caltabiano; Corrado Rubini; Tiziana Pieramici; Lorenzo Trevisiol; Francesco Carinci; Rosalia Leonardi; Alfredo De Lillo; Salvatore Lanzafame; Pantaleo Bufo; Adriano Piattelli
Journal:  Hum Pathol       Date:  2005-02       Impact factor: 3.466

8.  Immunohistochemical prognostication of Merkel cell carcinoma: p63 expression but not polyomavirus status correlates with outcome.

Authors:  Brian J Hall; Laura B Pincus; Siegrid S Yu; Dennis H Oh; Andrew R Wilson; Timothy H McCalmont
Journal:  J Cutan Pathol       Date:  2012-08-06       Impact factor: 1.587

9.  Elevated expression of p63 protein in human esophageal squamous cell carcinomas.

Authors:  Hai Hu; Shu-Hua Xia; Ai-Dong Li; Xin Xu; Yan Cai; Ya-Ling Han; Fang Wei; Bao-Sheng Chen; Xiao-Ping Huang; Yu-Sheng Han; Jian-Wei Zhang; Xun Zhang; Min Wu; Ming-Rong Wang
Journal:  Int J Cancer       Date:  2002-12-20       Impact factor: 7.396

10.  Why most published research findings are false.

Authors:  John P A Ioannidis
Journal:  PLoS Med       Date:  2005-08-30       Impact factor: 11.613

View more
  13 in total

1.  Detection of mitotic figures and G2+ tumor nuclei with histone markers correlates with worse overall survival in patients with Merkel cell carcinoma.

Authors:  Samuel A Henderson; Michael T Tetzlaff; Penvadee Pattanaprichakul; Patricia Fox; Carlos A Torres-Cabala; Roland L Bassett; Victor G Prieto; Hunter W Richards; Jonathan L Curry
Journal:  J Cutan Pathol       Date:  2014-10-28       Impact factor: 1.587

Review 2.  Update on Merkel Cell Carcinoma.

Authors:  Michael T Tetzlaff; Priyadharsini Nagarajan
Journal:  Head Neck Pathol       Date:  2018-03-20

Review 3.  Merkel cell carcinoma.

Authors:  Jürgen C Becker; Andreas Stang; James A DeCaprio; Lorenzo Cerroni; Celeste Lebbé; Michael Veness; Paul Nghiem
Journal:  Nat Rev Dis Primers       Date:  2017-10-26       Impact factor: 52.329

Review 4.  Milestones in the staging, classification, and biology of Merkel cell carcinoma.

Authors:  Ata S Moshiri; Paul Nghiem
Journal:  J Natl Compr Canc Netw       Date:  2014-09       Impact factor: 11.908

Review 5.  [Merkel cell carcinoma].

Authors:  I Fried; L Cerroni
Journal:  Pathologe       Date:  2014-09       Impact factor: 1.011

6.  Merkel Cell Carcinoma Analysis of Outcomes: A 30-Year Experience.

Authors:  Evan Liang; Jeffrey V Brower; Stephanie R Rice; Darya G Buehler; Sandeep Saha; Randall J Kimple
Journal:  PLoS One       Date:  2015-06-08       Impact factor: 3.240

Review 7.  Mutational analysis of merkel cell carcinoma.

Authors:  Derek J Erstad; James C Cusack
Journal:  Cancers (Basel)       Date:  2014-10-17       Impact factor: 6.639

8.  Merkel cell polyomavirus small T antigen is oncogenic in transgenic mice.

Authors:  Monique E Verhaegen; Doris Mangelberger; Paul W Harms; Tracy D Vozheiko; Jack W Weick; Dawn M Wilbert; Thomas L Saunders; Alexandre N Ermilov; Christopher K Bichakjian; Timothy M Johnson; Michael J Imperiale; Andrzej A Dlugosz
Journal:  J Invest Dermatol       Date:  2014-10-14       Impact factor: 8.551

9.  p63 expression confers significantly better survival outcomes in high-risk diffuse large B-cell lymphoma and demonstrates p53-like and p53-independent tumor suppressor function.

Authors:  Zijun Y Xu-Monette; Shanxiang Zhang; Xin Li; Ganiraju C Manyam; Xiao-Xiao Wang; Yi Xia; Carlo Visco; Alexandar Tzankov; Li Zhang; Santiago Montes-Moreno; Karen Dybkaer; April Chiu; Attilio Orazi; Youli Zu; Govind Bhagat; Kristy L Richards; Eric D Hsi; William W L Choi; J Han van Krieken; Jooryung Huh; Maurilio Ponzoni; Andrés J M Ferreri; Xiaoying Zhao; Michael B Møller; Ben M Parsons; Jane N Winter; Miguel A Piris; L Jeffrey Medeiros; Ken H Young
Journal:  Aging (Albany NY)       Date:  2016-02       Impact factor: 5.682

Review 10.  Diagnostic Immunohistochemistry in Cutaneous Neoplasia: An Update.

Authors:  Leigh A Compton; George F Murphy; Christine G Lian
Journal:  Dermatopathology (Basel)       Date:  2015-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.